Table 1 Efficacy and safety input data
Treatment | Treatment success rate (%) | Add-on rate (%) | Severe AEs/switch due to severe AEs (%) | Switch (due to other reason) (%) | AE rate (%) | Mortality rate (%) |
|---|---|---|---|---|---|---|
Voriconazole | 52.8 | 19.2 | 13.4 | 9.0 | 13.4 | 5.6 |
Liposomal amphotericin B | 50.0 | 8.7 | 20.0 | 16.0 | 20.0 | 5.3 |